查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046100

病患登記軟體市場 - 全球產業規模、佔有率、趨勢、機會、預測：按登記類型、軟體類型、最終用戶、地區和競爭對手分類，2021-2031 年

Patient Registry Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Registry, By Type of Software, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球病患登記軟體市場預計將從 2025 年的 26.8 億美元大幅成長至 2031 年的 47.1 億美元，複合年成長率為 9.85%。

這種專門的數位化解決方案旨在精準地收集、儲存和分析患有特定疾病或病症的個體的標準化數據。此類系統對於評估臨床結果、支持上市後監測以及推動孤兒藥的研發至關重要。推動該市場發展的關鍵因素包括：監管機構對「真實世界數據 (RWE)」的需求日益成長，以檢驗臨床試驗並加快藥物核准；慢性病和罕見病在全球範圍內的患病率不斷上升，需要進行可靠的縱向追蹤；以及醫療產業向價值醫療模式的轉變，這有利於利用這些平台來提升整體人群健康管理。不同醫療保健系統之間缺乏數據互通性和統一標準，給市場帶來了重大挑戰，阻礙了數據的無縫整合。這種碎片化常常造成資訊孤島，阻礙了多中心臨床研究所必需的全面分析。儘管存在這些挑戰，但該解決方案在一些細分領域的應用正在迅速發展。例如，根據國家罕見疾病組織 (NORD) 的一份報告，到 2025 年，IAMRARE 註冊平台將支援 70 多項由患者主導的自然病程研究，涉及 165 種罕見疾病的 20,000 多名參與者。

市場概覽
預測期 2027-2031
市場規模：2025年 26.8億美元
市場規模：2031年 47.1億美元
複合年成長率：2026-2031年 9.85%
成長最快的細分市場 醫院
最大的市場 北美洲

市場促進因素

藥物研發領域對真實世界證據 (RWE) 的需求日益成長，是推動病患登記軟體市場成長的主要動力。隨著監管機構和製藥公司越來越希望利用不同患者群體的廣泛縱向數據來支持臨床試驗結果，能夠聚合和分析大量資料集的平台需求激增。這種轉變正在將登記系統從單純的資料儲存庫轉變為動態工具，這些工具對於上市後監測和建構合成對照組至關重要，也使得複雜的軟體基礎設施不可或缺。例如，Verana Health 於 2025 年 3 月宣布增強其研究能力，旨在透過整合一個包含多達 8,000 萬名患者匿名記錄的真實世界資料庫，來支援更全面的臨床研究。如此龐大的數據量使相關人員能夠產生高品質的證據，從而加速新治療方法的核准，同時​​降低與傳統臨床試驗通常相關的成本和複雜性。同時，慢性病和罕見疾病發病率的上升正推動著登記解決方案的廣泛應用，這些解決方案對於有效的人群健康管理和提供以價值為導向的醫療保健至關重要。醫療保健系統越來越依賴這些數位平台來監測疾病進展、追蹤患者的長期預後，並為專門的研究舉措尋找合適的參與者。這一趨勢也得到了大規模國家計畫的支持。 2025年2月，美國國立衛生研究院 (NIH) 的「我們所有人」(All of Us)調查計畫擴展了其資料集，新增了超過63.3萬名參與者的資料。這使得可用於調查複雜健康狀況的資料量增加了50%。此外，公共部門對這些系統的持續投入也反映在新的資金撥款上。例如，安達盧西亞自治區政府於2026年1月宣布投資870萬歐元，用於一項新的護理計劃，其中包括引入一個專門的登記系統，以加強對罕見疾病的了解和服務。

市場挑戰

資料互通性不足以及醫療系統碎片化導致缺乏標準化格式，是全球病患登記軟體市場成長的重大障礙。病患登記系統的核心在於無縫整合來自不同來源的縱向健康數據，這些來源包括各種電子健康記錄、實驗室資訊系統和藥房資料庫。當這些系統因技術標準不一致而各自獨立運作時，資訊的順暢交換就會受到阻礙。這種碎片化迫使機構依賴繁瑣的手動資料輸入或開發複雜的自訂介面，從而顯著增加登記解決方案的營運成本並延長部署週期。因此，需要高效自動化資料收集機制的採用者往往猶豫不決。這種技術上的摩擦直接阻礙了市場擴張，限制了登記舉措在研究和價值醫療中的擴充性和即時可用性。醫療服務提供者通常不願投資那些無法與其現有基礎設施有效整合的平台。根據醫療資訊管理系統協會 (HIMSS) 的數據，到 2024 年，42% 的醫療機構將把來自多個電子健康記錄系統的數據整合視為提高互通性的最大障礙。這種整合不同資料來源的困難降低了註冊系統購買者的投資報酬率，並因此減緩了這些關鍵軟體平台在整個醫療生態系統中的普及速度。

市場趨勢

人工智慧 (AI) 在預測分析領域的應用正在顯著改變患者登記軟體，使其能夠從以往非結構化的資料來源中自動提取有價值的資訊。傳統的登記系統依賴結構化字段，而如今，先進的機器學習演算法可以處理臨床記錄、醫學影像和病理報告，從而更準確地識別臨床試驗參與者並預測疾病進展。這項功能有效地將未充分利用的文字轉化為可用於複雜研究的可操作資料集，使平台的功能超越了單純的資料儲存。例如，在 2025 年 2 月，Verana Health 在一份關於新策略合作夥伴關係的企業新聞稿中重點介紹了用於分析非結構化臨床記錄的 AI 工具。該工具成功識別出可能被標準編碼查詢遺漏的視網膜色素變性患者，從而推動了基因療法的研發。同時，穿戴式裝置在即時數據採集方面的日益普及正在拓展登記系統的範圍，使其從零散的門診記錄轉向持續的生理監測。透過收集高頻患者自發性健康數據，例如心率變異性和活動水平，現代平台能夠在真實的臨床環境中建立更全面的患者健康狀況和治療效果整體情況。這一趨勢正在迅速增加可用於上市後監測和慢性病管理的縱向數據的數量和詳細程度。例如，Validic 在 2025 年 10 月的 HLTH 大會上宣布其生態系統擴展計劃，並表示其穿戴式資料整合平台目前支援超過 600 種連網裝置。這項功能使全國性醫療服務提供者能夠將超過 50 萬名患者納入持續遠距監測計畫。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球病患登記軟體市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依登記類型（疾病登記、醫療服務登記、產品登記）
    • 軟體類型（獨立軟體、整合軟體）
    • 按最終用戶分類（醫院、政府機構和第三方監管機構 (TPA)、製藥公司、生物技術公司、醫療設備公司等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美病患登記軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲病患登記軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區病患登記軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲病患登記軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲病患登記軟體市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球病患登記軟體市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • IBM Corporation
  • IQVIA Holdings, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • McKesson Corporation
  • ImageTrend, Inc.
  • Dacima Software Inc.
  • Syneos Health Inc.
  • Global Vision Technologies, Inc.
  • Evado eClinical Solutions

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16848

The Global Patient Registry Software Market is projected to expand significantly, rising from USD 2.68 Billion in 2025 to USD 4.71 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 9.85%. This specialized digital solution is designed to meticulously collect, store, and analyze standardized data on individuals with specific diseases or conditions. Such systems are crucial for evaluating clinical outcomes, supporting post-market surveillance, and advancing the development of orphan drugs. Key drivers for this market include the escalating demand from regulatory bodies for Real-World Evidence (RWE) to validate clinical trials and expedite drug approvals, the increasing global prevalence of chronic and rare diseases requiring robust longitudinal tracking, and the healthcare industry's shift towards value-based care, which promotes these platforms for enhanced population health management. Data interoperability and the absence of uniform standards across disparate healthcare systems present a significant challenge for the market, hindering seamless data integration. This fragmentation often creates isolated information silos, impeding the comprehensive analysis vital for multi-site clinical studies. Despite these challenges, there is notable adoption in niche sectors; for instance, in 2025, the IAMRARE registry platform, as reported by the National Organization for Rare Disorders, facilitated over 70 patient-powered natural history studies, encompassing more than 20,000 participants across 165 distinct rare diseases.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.68 Billion
Market Size 2031USD 4.71 Billion
CAGR 2026-20319.85%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Market Driver

The increasing requirement for Real-World Evidence (RWE) in drug development serves as the primary impetus for the patient registry software market's growth. As regulatory bodies and pharmaceutical companies increasingly seek to corroborate clinical trial findings with extensive longitudinal data from diverse patient populations, the need for platforms capable of aggregating and analyzing vast datasets has soared. This evolution is transforming registries from mere data repositories into dynamic tools crucial for post-marketing surveillance and the creation of synthetic control arms, thus necessitating advanced software infrastructure. To illustrate the magnitude of data now being utilized, Verana Health announced in March 2025 an enhancement to its research capabilities by integrating a real-world database containing de-identified records from up to 80 million patients, aimed at supporting more inclusive clinical studies. Access to such extensive data empowers stakeholders to generate high-quality evidence, thereby accelerating the approval of new therapies while simultaneously reducing the costs and complexities typically associated with traditional trials. Concurrently, the rising incidence of chronic and rare diseases is fueling the broad adoption of registry solutions, essential for effective population health management and the delivery of value-based care. Healthcare systems are increasingly relying on these digital platforms to monitor disease progression, track long-term patient outcomes, and identify suitable participants for specialized research initiatives. This trend is underscored by significant national programs; in February 2025, the National Institutes of Health's All of Us Research Program expanded its dataset to include information from over 633,000 participants, representing a 50% increase in the volume of data available for studying complex health conditions. Furthermore, sustained public sector commitment to these systems is evident through new funding allocations, such as the €8.7 million investment announced by the Andalucia Government in January 2026 for a new care plan that includes the deployment of a specialized registry system to enhance knowledge and services for rare diseases.

Market Challenge

Data interoperability and the absence of standardized formats across fragmented healthcare systems pose a significant impediment to the growth of the Global Patient Registry Software Market. Patient registries fundamentally depend on the seamless aggregation of longitudinal health data from diverse sources, including various electronic health records, laboratory information systems, and pharmacy databases. When these systems operate in isolation due to incompatible technical standards, the fluid exchange of information becomes obstructed. This fragmentation forces organizations to resort to labor-intensive manual data entry or develop complex custom interfaces, which substantially inflates the operational costs and extends the implementation timeline for registry solutions. Consequently, this discourages potential adopters who require efficient, automated data capture mechanisms. This technical friction directly hinders market expansion by restricting the scalability and immediate practical utility of registry initiatives for both research and value-based care. Healthcare providers are often reluctant to invest in platforms that cannot effectively communicate with their existing infrastructure. According to the Healthcare Information and Management Systems Society, in 2024, 42% of healthcare organizations identified integrating data from multiple electronic health record systems as their most formidable obstacle to improving interoperability. This high degree of difficulty in harmonizing disparate data sources reduces the return on investment for registry buyers, thereby decelerating the broader adoption of these critical software platforms across the entire healthcare ecosystem.

Market Trends

The integration of Artificial Intelligence (AI) for predictive analytics is profoundly transforming patient registry software by enabling the automated extraction of valuable insights from previously unstructured data sources. While registries traditionally relied on structured fields, advanced machine learning algorithms can now process clinical notes, medical imaging, and pathology reports to more precisely identify eligible trial participants and forecast disease progression. This capability effectively converts dormant text into actionable datasets for complex research, pushing platforms beyond simple data storage. For example, in February 2025, Verana Health, in a corporate press release concerning a new strategic partnership, highlighted its deployment of AI tools to analyze unstructured clinical notes, successfully identifying patients with Retinitis Pigmentosa for gene therapy development who would have been overlooked by standard coding queries. Simultaneously, the increasing use of wearable devices for real-time data capture is expanding the scope of registries, moving beyond episodic clinical visits to continuous physiological monitoring. By ingesting high-frequency patient-generated health data, such as heart rate variability and activity levels, modern platforms can construct a more holistic view of patient health and treatment efficacy in real-world environments. This trend is rapidly increasing both the volume and granularity of longitudinal data available for post-marketing surveillance and chronic disease management. Illustrating this growth, Validic stated in October 2025, during its ecosystem expansion announcement at the HLTH conference, that its wearable data integration platform now supports over 600 connected devices, a capability that allowed a single national provider to enroll more than 500,000 patients into continuous remote monitoring programs.

Key Market Players

  • IBM Corporation
  • IQVIA Holdings, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • McKesson Corporation
  • ImageTrend, Inc.
  • Dacima Software Inc.
  • Syneos Health Inc.
  • Global Vision Technologies, Inc.
  • Evado eClinical Solutions

Report Scope

In this report, the Global Patient Registry Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Patient Registry Software Market, By Type of Registry

  • Disease Registries
  • Health Service Registries
  • Product Registries

Patient Registry Software Market, By Type of Software

  • Stand-alone Software
  • Integrated Software

Patient Registry Software Market, By End User

  • Hospitals
  • Government Organizations and Third-Party Administrators (TPAs)
  • Pharmaceutical
  • Biotechnology
  • Medical Device Companies
  • Other

Patient Registry Software Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Patient Registry Software Market.

Available Customizations:

Global Patient Registry Software Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Patient Registry Software Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Registry (Disease Registries, Health Service Registries, Product Registries)
    • 5.2.2. By Type of Software (Stand-alone Software, Integrated Software)
    • 5.2.3. By End User (Hospitals, Government Organizations and Third-Party Administrators (TPAs), Pharmaceutical, Biotechnology, Medical Device Companies, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Patient Registry Software Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Registry
    • 6.2.2. By Type of Software
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Patient Registry Software Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Registry
        • 6.3.1.2.2. By Type of Software
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Patient Registry Software Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Registry
        • 6.3.2.2.2. By Type of Software
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Patient Registry Software Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Registry
        • 6.3.3.2.2. By Type of Software
        • 6.3.3.2.3. By End User

7. Europe Patient Registry Software Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Registry
    • 7.2.2. By Type of Software
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Patient Registry Software Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Registry
        • 7.3.1.2.2. By Type of Software
        • 7.3.1.2.3. By End User
    • 7.3.2. France Patient Registry Software Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Registry
        • 7.3.2.2.2. By Type of Software
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Patient Registry Software Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Registry
        • 7.3.3.2.2. By Type of Software
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Patient Registry Software Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Registry
        • 7.3.4.2.2. By Type of Software
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Patient Registry Software Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Registry
        • 7.3.5.2.2. By Type of Software
        • 7.3.5.2.3. By End User

8. Asia Pacific Patient Registry Software Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Registry
    • 8.2.2. By Type of Software
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Patient Registry Software Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Registry
        • 8.3.1.2.2. By Type of Software
        • 8.3.1.2.3. By End User
    • 8.3.2. India Patient Registry Software Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Registry
        • 8.3.2.2.2. By Type of Software
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Patient Registry Software Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Registry
        • 8.3.3.2.2. By Type of Software
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Patient Registry Software Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Registry
        • 8.3.4.2.2. By Type of Software
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Patient Registry Software Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Registry
        • 8.3.5.2.2. By Type of Software
        • 8.3.5.2.3. By End User

9. Middle East & Africa Patient Registry Software Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Registry
    • 9.2.2. By Type of Software
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Patient Registry Software Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Registry
        • 9.3.1.2.2. By Type of Software
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Patient Registry Software Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Registry
        • 9.3.2.2.2. By Type of Software
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Patient Registry Software Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Registry
        • 9.3.3.2.2. By Type of Software
        • 9.3.3.2.3. By End User

10. South America Patient Registry Software Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Registry
    • 10.2.2. By Type of Software
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Patient Registry Software Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Registry
        • 10.3.1.2.2. By Type of Software
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Patient Registry Software Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Registry
        • 10.3.2.2.2. By Type of Software
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Patient Registry Software Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Registry
        • 10.3.3.2.2. By Type of Software
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Patient Registry Software Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. IBM Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IQVIA Holdings, Inc.
  • 15.3. Optum, Inc.
  • 15.4. Oracle Corporation
  • 15.5. McKesson Corporation
  • 15.6. ImageTrend, Inc.
  • 15.7. Dacima Software Inc.
  • 15.8. Syneos Health Inc.
  • 15.9. Global Vision Technologies, Inc.
  • 15.10. Evado eClinical Solutions

16. Strategic Recommendations

17. About Us & Disclaimer